Kevin M. Brady Net Worth

The estimated Net Worth of Kevin M. Brady is at least $4.81 Million dollars as of 31 July 2023. Mr Brady owns over 10,000 units of Medpace Inc stock worth over $4,349,410 and over the last 3 years he sold MEDP stock worth over $457,840.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr Brady MEDP stock SEC Form 4 insiders trading

Mr has made over 3 trades of the Medpace Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he exercised 10,000 units of MEDP stock worth $906,500 on 31 July 2023.

The largest trade he's ever made was exercising 10,000 units of Medpace Inc stock on 31 July 2023 worth over $906,500. On average, Mr trades about 2,208 units every 106 days since 2021. As of 31 July 2023 he still owns at least 13,000 units of Medpace Inc stock.

You can see the complete history of Mr Brady stock trades at the bottom of the page.

Mr. Kevin M. Brady biography

Kevin M. Brady is the CFO & Treasurer at Medpace Inc.

How old is Mr Brady?

Mr Brady is 47, he's been the CFO & Treasurer of Medpace Inc since . There are 11 older and 2 younger executives at Medpace Inc. The oldest executive at Medpace Holdings Inc is Fred Davenport, 68, who is the Lead Independent Director.

What's Mr Brady's mailing address?

Kevin's mailing address filed with the SEC is C/O MEDPACE HOLDINGS, INC., 5375 MEDPACE WAY, CINCINNATI, OH, 45227.

Insiders trading at Medpace Inc

Over the last 8 years, insiders at Medpace Inc have traded over $3,140,136,825 worth of Medpace Inc stock and bought 2,899,276 units worth $330,034,155 . The most active insiders traders include Limited Partnership Medpace..., August J. Troendle und Investors, Llc Medpace. On average, Medpace Inc executives and independent directors trade stock every 9 days with the average trade being worth of $40,224,347. The most recent stock trade was executed by Robert O. Kraft on 22 August 2024, trading 8,127 units of MEDP stock currently worth $346,373.

What does Medpace Inc do?

a therapeutically focused leader in research-based drug development, medpace builds strong strategic partnerships with select sponsors to advance the most efficient and cost-effective path to drug approval. as a full service, global clinical research organization (cro), medpace sees itself as a steward of your drug, leveraging its extensive medical and regulatory expertise to deliver additional input, strategy, and efficiencies to each and every phase of the clinical trial. from custom solutions addressing the needs of small and midsize biotechnology companies to full-service offerings for global pharmaceutical companies, medpace has the breadth, depth, and flexibility to deliver a superior result, specific to your needs, on six continents.

Complete history of Mr Brady stock trades at Medpace Inc

Medpace Inc executives and stock owners

Medpace Inc executives and other stock owners filed with the SEC include:

• August Troendle,
  Chairman of the Board, President, Chief Executive Officer
• Susan Burwig,
  Executive Vice President - Operations
• Jesse Geiger,
  Chief Financial Officer, Chief Operating Officer - Laboratory Operations
• Stephen Ewald,
  General Counsel, Corporate Secretary
• Dr. August James Troendle M.D.,
  Chairman & CEO
• Susan E. Burwig,
  Exec. VP of Operations
• Jesse J. Geiger BBA, CPA,
  Pres
• Stephen P. Ewald,
  Chief Compliance Officer, Gen. Counsel & Corp. Sec.
• Brian Carley,
  Independent Director
• Robert Kraft,
  Independent Director
• Fred Davenport,
  Lead Independent Director
• Cornelius McCarthy,
  Independent Director
• Ashley Keating,
  Independent Director
• Thomas King,
  Independent Director
• Brandon Ebken,
  Chief Information Officer
• John T. Wynne,
  Sr. VP of Commercial Operations & Clinical Pharmacology Unit
• Daniel O'Leary,
  Sr. VP of Medical Department
• Weimin Gai MS,
  Sr. VP of Biometrics
• Todd Meyers,
  VP of Bus. Devel. & Marketing
• Lauren Morris,
  Associate Director of Investors Relations
• Kevin M. Brady,
  CFO & Treasurer
• Penelope J Bucknell,
  VP, Human Resources
• Bruce Brown,
  Director
• Cinven Fund (No. 1) Limited...,
  
• Limited Partnership Medpace...,
  
• Dani S. Zander,
  Director
• Investors, Llc Medpace,
  10% owner
• Tom C King,
  Director
• Kevin M. Brady,
  CFO & Treasurer